TenNor Therapeutics raised $41 million in a series E financing round led by AMR Action Fund to advance the development of rifasutenizol for Helicobacter pylori infections.
Amount Raised
$41 Million
Round Type
Series E
Suzhou CityBiotechnologyHealth CareTherapeuticsInvestors
Description
TenNor Therapeutics, a Suzhou-based biotech company, announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). The funds will be used to advance the development of their potential new therapy for Helicobacter pylori infections.
Quick answer
TenNor Therapeutics raised $41 Million in a Series E round, dated October 16, 2024. Investors: Zhongshan Venture Capital and AMR Action Fund. TenNor Therapeutics is based in Suzhou City, Jiangsu, China.
- How much did TenNor Therapeutics raise?
- TenNor Therapeutics raised $41 Million in a Series E round on October 16, 2024.
- Who invested in TenNor Therapeutics?
- Zhongshan Venture Capital and AMR Action Fund are named as investors in this round.
- What does TenNor Therapeutics do?
- TenNor Therapeutics is a clinical-stage biotech company based in Suzhou, focused on developing therapies for bacterial infections and metabolic diseases.
- Where is TenNor Therapeutics based and how big is it?
- TenNor Therapeutics is based in Suzhou City, Jiangsu, China.
- Who are the decision-makers at TenNor Therapeutics?
- Fundz holds 2 contacts at TenNor Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as TenNor Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Celosia Therapeutics raised $17M (Series A) on November 28, 2024.
- Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
- Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
- Biofrontera raised $4.2M (Seed) on November 21, 2024.
- HCW Biologics raised $6.9M on November 20, 2024.
- Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
Who to call at TenNor Therapeutics, and when
A new round usually means TenNor Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TenNor Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TenNor Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TenNor Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TenNor Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TenNor Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.